First Horizon Corporation’s Ionis Pharmaceuticals IONS Stock Holding History

First Horizon Corporation’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.92K	Buy	62 +6	+11%	+$452	﹤0.01%	1235
2026 Q1	$4.21K	Buy	56 +31	+124%	+$2.45K	﹤0.01%	1181
2025 Q4	$1.98K	Buy	+25	New	+$1.88K	﹤0.01%	1323
2021 Q2	$0	Hold	6	–	–	﹤0.01%	1137
2021 Q1	$0	Hold	6	–	–	﹤0.01%	1126
2020 Q4	$0	Hold	6	–	–	﹤0.01%	1150
2020 Q3	$0	Buy	+6	New	+$333	﹤0.01%	1097

Other funds holding IONS

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

CUAMC

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

First Horizon Corporation's IONS Position: Q2 2026 in Review

First Horizon Corporation increased its Ionis Pharmaceuticals (IONS) stake by 11% in Q2 2026, buying an estimated $452 and bringing the position to 62 shares worth $4.92K. The position accounts for ﹤0.01% of the portfolio, ranked #1235.

First Horizon Corporation first reported a position in IONS in Q3 2020 and has held it in 7 quarters since. 130 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

First Horizon Corporation held 62 shares of Ionis Pharmaceuticals worth $4.92K as of Q2 2026.
First Horizon Corporation bought 6 Ionis Pharmaceuticals shares in Q2 2026, an estimated $452.
Ionis Pharmaceuticals made up ﹤0.01% of First Horizon Corporation's portfolio in Q2 2026, its #1235 holding.
First Horizon Corporation first reported a position in Ionis Pharmaceuticals in Q3 2020 and has held it in 7 quarters since.
130 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on First Horizon Corporation's 13F filing for Q2 2026, filed 20 Jul 2026.